Calpain inhibition protects against Taxol-induced sensory neuropathy

Brain

Volumn 127, Issue 3, 2004, Pages 671-679

  Wang, Min Sheng ^a   Davis, Albert A ^a   Culver, Deborah G ^a   Wang, Qinbo ^a   Powers, James C ^b   Glass, Jonathan D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Axon; Axonal degeneration; Calpain; Paclitaxel; Peripheral neuropathy

Indexed keywords

AK 295; ANTINEOPLASTIC AGENT; CALPAIN; CALPASTATIN; PACLITAXEL; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG INDUCED DISEASE; FEMALE; IMAGE ANALYSIS; MICROTUBULE; NERVE CELL NECROSIS; NERVE FIBER DEGENERATION; NEUROPATHY; NEUROPROTECTION; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SENSORY NEUROPATHY; SPINAL GANGLION;

ANIMALS; ANTINEOPLASTIC AGENTS; AXONS; CALPAIN; CASPASES; CELL DEATH; CELL LINE; CELLS, CULTURED; DIPEPTIDES; ELECTROPHYSIOLOGY; FEMALE; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; MICROTUBULES; NERVE DEGENERATION; NEURONS, AFFERENT; PACLITAXEL; RATS; RATS, INBRED STRAINS;

EID: 1542316091     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh078     Document Type: Article

References (43)

1. Asgian JL, James KE, Li ZZ, Carter W, Barrett AJ, Mikolajczyk J, et al. Aza-peptide epoxides: a new class of inhibitors selective for clan CD cysteine proteases. J Med Chem 2002; 45: 4958-60.
2. Authier N, Gillet JP, Fialip J, Eschalier A, Coudore F. Description of a short-term Taxol-induced nociceptive neuropathy in rats. Brain Res 2000; 887: 239-49.
3. Bartus R. The calpain hypothesis of neurodegeneration: evidence for a common cytotoxic pathway. Neuroscientist 1997; 3: 314-27.
4. Bartus RT, Hayward NJ, Elliott PJ, Sawyer SD, Baker KL, Dean RL, et al. Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of postocclusion intra-arterial administration. Stroke 1994; 25: 2265-70.
5. Bartus RT, Elliott PJ, Hayward NJ, Dean RL, Harbeson S, Straub JA, et al. Calpain as a novel target for treating acute neurodegenerative disorders. Neurol Res 1995; 17: 249-58.
6. Black MM. Taxol interfers with the interaction of microtubule-associated proteins with microtubules in cultured neurons. J Neurosci 1987; 7: 3695-702.
7. Blagosklonny MV, Schulte T, Nguyen P, Trepel J, Neckers LM. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res 1996; 56: 1851-4.
8. Bronk SF, Gores GJ. pH-dependent nonlysosomal proteolysis contributes to lethal anoxic injury of rat hepatocytes. Am J Physiol 1993; 264: G744-51.
9. Caner H, Collins JL, Harris SM, Kassell NF, Lee KS. Attenuation of AMPA-induced neurotoxicity by a calpain inhibitor. Brain Res 1993; 607: 354-6.
10. Cavaletti G, Tredici G, Braga M, Tazzari S. Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol. Exp Neurol 1995; 133: 64-72.
11. Choi D. NMDA receptors and AMPA/kainate receptors mediate parallel injury in cerebral cortical cultures subjected to oxygen-glucose deprivation. Prog Brain Res 1993; 96: 137-43.
12. Croall DE, DeMartino GN. Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol Rev 1991; 71: 813-47.
13. Giannakakou P, Villalba L, Li H, Poruchynsky M, Fojo T. Combinations of paclitaxel and vinblastine and their effects on tubulin polymerization and cellular cytotoxicity: characterization of a synergistic schedule. Int J Cancer 1998; 75: 57-63.
14. Griffin JW, Watson DF. Axonal transport in neurological disease. Ann Neurol 1988; 23: 3-13.
15. James T, Matzelle D, Bartus R, Hogan EL, Banik NL. New inhibitors of calpain prevent degradation of cytoskeletal and myelin proteins in spinal cord in vitro. J Neurosci Res 1998; 51: 218-22.
16. 2+-activated neutral protease in the peripheral nerve and its effects on neurofilament degeneration. J Neurochem 1983; 40: 908-13.
17. Kaplan JG, Einzig AI, Schaumburg HH. Taxol causes permanent large fiber peripheral nerve dysfunction: a lesson for preventative strategies. J Neurooncol 1993; 16: 105-7.
18. Li ZH, Hogan EL, Banik N. Role of calpain in spinal cord injury: increased mcalpain immunoreactivity in spinal cord after compression injury in the rat. Neurochem Int 1995; 27: 425-32.
19. Li Z, Hogan EL, Banik NL. Role of calpain in spinal cord injury: increased calpain immunoreactivity in rat spinal cord after impact trauma. Neurochem Res 1996a; 21: 441-8.
20. Li Z, Ortega-Vilain A-C, Patil GS, Chu D-L, Foreman JE, Eveleth DD, et al. Novel peptidyl α-keto amide inhibitors of calpains and other cysteine proteases. J Med Chem 1996b; 39: 4089-98.
21. Lipton RB, Apfel SC, Dutcher JP, Rosenberg R, Kaplan J, Berger A, et al. Taxol produces a predominantly sensory neuropathy. Neurology 1989; 39: 368-73.
22. LoPachin RM, Lehning EJ. Mechanism of calcium entry during axon injury and degeneration. Toxicol Appl Pharmacol 1997; 143: 233-44.
23. Meldrum B, Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 1990; 11: 379-87.
24. Melloni E, Salamino F, Sparatore B. The calpain-calpastatin system in mammalian cells: properties and possible functions. Biochimie 1992; 74: 217-23.
25. Mimura Y, Kato H, Eguchi K, Ogawa T. Schedule dependency of paclitaxel-induced neuropathy in mice: a morphological study. Neurotoxicology 2000; 21: 513-20.
26. Mouatt-Prigent A, Karlsson JO, Agid Y, Hirsch EC. Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? Neuroscience 1996; 73: 979-87.
27. Nakata T, Yorifuji H. Morphological evidence of the inhibitory effect of taxol on the fast axonal transport. Neurosci Res 1999; 35: 113-22.
28. Nixon RA. Calcium-activated neutral proteinases as regulators of cellular function. Implications for Alzheimer's disease pathogenesis. Ann NY Acad Sci 1989; 568: 198-208.
29. Nixon RA, Saito KI, Grynspan F, Griffin WR, Katayama S, Honda T, et al. Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann NY Acad Sci 1994; 747: 77-91.
30. Oyaizu H, Adachi Y, Taketani S, Tokunaga R, Fukuhara S, Ikehara S. A crucial role of caspase 3 and caspase 8 in paclitaxel-induced apoptosis. Mol Cell Biol Res Commun 1999; 2: 36-41.
31. Ray SK, Wilford GG, Ali SF, Banik NL. Calpain upregulation in spinal cords of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease. Ann NY Acad Sci 2000; 914: 275-83.
32. Rowinsky EK, Chaudhry V, Comblath DR, Donehower RC. Neurotoxicity of Taxol. J Natl Cancer Inst Monogr 1993; 15: 107-15.
33. Roytta M, Raine CS. Taxol-induced neuropathy: further ultrastructural studies of nerve fibre changes in situ. J Neurocytol 1985; 14: 157-75.
34. Saatman KE, Bozyczko-Coyne D, Marcy V, Siman R, McIntosh TK. Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J Neuropathol Exp Neurolol 1996a; 55: 850-60.
35. Saatman KE, Murai H, Bartus RT, Smith DH, Hayward NJ, Perri BR, et al. Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat. Proc Natl Acad Sci USA 1996b; 93: 3428-33.
36. Sahenk Z, Barohn R, New P, Mendell JR. Taxol neuropathy. Electrodiagnostic and sural nerve biopsy findings. Arch Neurol 1994; 51: 726-9.
37. Schlaepfer WW, Zimmerman UP. Calcium-activated protease and the regulation of the axonal cytoskeleton. In: Elam JS, Cancalon P, editors. Axonal transport in neuronal growth and regeneration. New York: Plenum Press; 1984. p. 261-73.
38. Siman R, Bozyczko-Coyne D, Savage MJ, Roberts-Lewis JM. The calcium-activated protease calpain I and ischemia-induced neurodegeneration. Adv Neurol 1996; 71: 167-74.
39. Theiss C, Meller K. Taxol impairs anterograde axonal transport of microinjected horseradish peroxidase in dorsal root ganglia neurons in vitro. Cell Tissue Res 2000; 299: 213-24.
40. Wang MS, Wu Y, Culver DG, Glass JD. Pathogenesis of axonal degeneration: parallels between Wallerian degeneration and vincristine neuropathy. J Neuropathol Exp Neurolol 2000; 59: 599-606.
41. Wang MS, Davis AA, Culver DG, Glass JD. WldS mice are resistant to paclitaxel (taxol) neuropathy. Ann Neurol 2002; 52: 442-7.
42. Weber H, Hopp HH, Wagner AC, Noack T, Jonas L, Luthen F, et al. Expression and regulation of calpain in rat pancreatic acinar cells. Pancreas 2002; 24: 63-74.
43. Windebank AJ. Chemotherapeutic neuropathy. Curr Opin Neurol 1999; 12: 565-71.